InMed director Janet Grove fails re-election; resignation tendered per majority voting policy

InMed Pharmaceuticals Inc.

Janet Grove received only 44.26% votes for (55.74% withheld); per policy she tendered resignation to Board chair.
Nominating & Governance Committee will review whether to accept Grove's resignation; update to follow.
Four other director nominees re-elected with >96% votes for each (Adams, Hull, Lemerond, Baldasare).
Shareholders approved appointment of Marcum LLP (now CBIZ LLP) as independent auditor for the next year.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.